Subscribe to Steven Schnelle's Posts
Steven Schnelle delivers strategic solutions to investors and business operators in the healthcare and life sciences industries. He advises a full spectrum of investors, healthcare and life sciences organizations, providing insight for clients navigating the complex legal structures defining these tightly regulated sectors. Learn more about Steven's practice here.
By Emily Jane Cook and Steven Schnelle on Oct 27, 2023
Posted In 340B
On October 26, the Health Resources and Services Administration (HRSA) published a Federal Register notice addressing the use of 340B drugs at off-campus hospital outpatient locations that have not yet appeared on a filed Medicare cost report. These locations are known as “unregistered child sites.” In the notice, HRSA maintains that its prior policy allowing...